HC Surgical Specialists Limited (SGX:1B1)

Market Cap	52.15M
Revenue (ttm)	19.30M
Net Income (ttm)	8.44M
Shares Out	153.38M
EPS (ttm)	0.05
PE Ratio	6.19
Forward PE	n/a
Dividend	0.02 (6.94%)
Ex-Dividend Date	Oct 31, 2025

Volume	55,000
Average Volume	32,010
Open	0.3400
Previous Close	0.3400
Day's Range	0.3400 - 0.3400
52-Week Range	0.2700 - 0.3750
Beta	-0.20
RSI	46.50
Earnings Date	Jan 10, 2026

About HC Surgical Specialists

HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal fissure, hernia, anal abscess, cholecystitis, anal fistula, appendicitis, colorectal cancer, lipomas, cysts, and gastric cancer, vein laser vascular, laparoscopy, and other g...

• Industry: Offices and Clinics of Doctors of Medicine
• Founded: 2015
• Country: Singapore
• Stock Exchange: Singapore Exchange - Catalist
• Ticker Symbol: 1B1

Financial Performance

In 2025, HC Surgical Specialists's revenue was 19.30 million, an increase of 1.77% compared to the previous year's 18.97 million. Earnings were 8.44 million, an increase of 119.42%.